In this special ACC.22 episode of Eagle’s Eye View, Drs. Kim Eagle, Payal Kohli and Deepak Bhatt discuss highlights from Day 2 of the ACC.22 late-breaking science and featured clinical research, including PACMAN AMI, SuperWIN, DIAMOND, and IVVE.

In this special ACC.22 episode of Eagle’s Eye View, Drs. Kim Eagle, Payal Kohli and Deepak Bhatt discuss highlights from Day 1 of the ACC.22 late-breaking science and featured clinical research, including CHAP, SCORED, COMPLETE, and Bentracimab.

In this week’s View, Dr. Eagle discusses a new Expert Consensus Decision Pathway released by the ACC that addresses the evaluation and management of some of the more common cardiovascular sequelae in adults with COVID-19. The Pathway, published March 16 in the Journal of the American College of Cardiology, specifically addresses myocarditis and other types of myocardial involvement, patient-centered approaches for long COVID, and offers guidance on resumption of exercise following COVID-19.

In this View episode, guest host Deepak Bhatt, MD, MPH, FACC, offers a preview of some of the hottest trials at the ACC 2022 Conference being held April 2-4. ACC 2022 promises to be a rich and rewarding experience, in person and virtually.

In this week’s View, Dr. Eagle discusses a comparison of patients infected with Delta versus Omicron COVID-19 variants, then looks at a post-hoc analysis of the EMPEROR-Preserved trial on mineralocorticoid receptor antagonists and empagliflozin in patients with heart failure and preserved ejection fraction. Finally, Dr. Eagle explores a recent NCDR Registry paper on sex differences in management and outcomes of acute myocardial infarction patients presenting with cardiogenic shock.

In this week’s View, Dr. Eagle discusses the effect of Pelacarsen on lipoprotein(a) cholesterol and corrected low density lipoprotein cholesterol. He also explores a systematic review and meta-analysis of bariatric surgery and cardiovascular disease. And finally, Dr. Eagle highlights a recent sub-study on the comprehensive quality of life outcomes with Invasive versus conservative management of chronic coronary disease in the ISCHEMIA trial.

In this week’s View, Dr. Eagle discusses a JACC State-of-the-Art Review on left ventricular thrombus following acute myocardial infarction. He also highlights the PARTNER 3 Bicuspid Registry for transcatheter aortic valve replacement in low surgical risk patients. And finally, Dr. Eagle explores the JACC paper on restoring sinus rhythm to reverse cardiac remodeling and reduce valvular regurgitation in patients with atrial fibrillation.

In this week’s View, Dr. Eagle discusses sodium-containing acetaminophen and cardiovascular outcomes in individuals with and without hypertension. He also examines anticoagulation in patients with COVID-19. Finally, Dr. Eagle explores JACC’s Review Topic of the Week: renal compression in heart failure – specifically, the Renal Tamponade Hypothesis.

In this week’s View, Dr. Eagle highlights a meta-analysis of statin intolerance. He also discusses the estimation of recurrent atherosclerotic cardiovascular event risk. And finally, Dr. Eagle reviews SARS-CoV-2 reinfection with and without mRNA vaccine.

In this week’s View, Dr. Eagle highlights a study comparing a proteomics-based risk model to a traditional risk factor model in predicting recurrent atherosclerotic events in two observational cohorts, He also discusses the prevalence of noncalcified and calcified plaque in symptomatic adults and its association with cardiovascular disease (CVD) events across the low-density lipoprotein cholesterol (LDL-C) spectrum. And finally, Dr. Eagle reviews the effects of empagliflozin on heart failure hospitalizations across the full range of left ventricular ejection fractions.